Indeed, it has been demonstrated that APOE4 carriers may show peculiar, and more extensive, regions of hypometabolism with respect to the general AD population thus possibly having partially influenced the results of the present analysis (Mosconi et al., 2004a). This evidence concerns the gene APOE and Alzheimer disease.